Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed)
This grant opportunity is for applicants interested in improving and understanding technologies and tests that could be used in regulatory submissions for genome editing therapies.
Source
Dates
Program & Phase
Keywords
Supporting Links
Documents
Similar Opportunities
-
Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
National Institutes of Health
-
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
National Institutes of Health
-
RFA: EDS Accelerator Award
American Cancer Society
-
DoW Autism Clinical Trial Award
Dept. of the Army -- USAMRAA
-
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
National Institutes of Health
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers